GWAS and multiple candidate gene studies have identified GCKR variants as being linked to several metabolic parameters, including triglyceride (TG) levels, insulin resistance, and fasting plasma glucose levels [34–36], as well as metabolic disorders like T2DM and dyslipidemia [37, 38]. The gene discussed is GCKR; the disease is Other metabolic disease.